九安医疗：预计2025年净利润同比增长21.05%-40.83%

Core Viewpoint - The company expects a net profit of 2.02 billion to 2.35 billion yuan for the fiscal year 2025, representing a year-on-year growth of 21.05% to 40.83% [1] Group 1: Financial Performance - The company's net profit has increased compared to the same period last year, primarily driven by strong performance in asset management business regarding major asset allocation [1] - The projected net profit range for 2025 indicates a positive outlook for the company's financial health and growth trajectory [1] Group 2: Product Demand - Demand for the company's reagent kits, which serve as regular home screening tools for respiratory viruses, remains stable [1] - The market for home healthcare electronic products continues to show consistent demand, contributing to the company's revenue growth [1]